These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6813888)

  • 41. Lithium in the treatment of mania: comparisons with neuroleptics.
    Goodwin FK; Zis AP
    Arch Gen Psychiatry; 1979 Jul; 36(8 Spec No):840-4. PubMed ID: 36866
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of thiothixene with chlorpromazine in the treatment of mania.
    Janicak PG; Bresnahan DB; Sharma R; Davis JM; Comaty JE; Malinick C
    J Clin Psychopharmacol; 1988 Feb; 8(1):33-7. PubMed ID: 3280617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lithium response in good prognosis schizophrenia.
    Hirschowitz J; Casper R; Garver DL; Chang S
    Am J Psychiatry; 1980 Aug; 137(8):916-20. PubMed ID: 7416291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relapse in patients with shifting RDC diagnoses treated with lithium alone.
    Glazer WM; Sheard MH
    J Clin Psychiatry; 1982 Apr; 43(4):134-6. PubMed ID: 7068543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypomania as a stable state: lithium prophylaxis in two patients.
    Burten W; Ballard BL
    Am J Psychiatry; 1981 Apr; 138(4):523-4. PubMed ID: 7212116
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of lithium carbonate on alcoholism in 20 male patients with concurrent major affective disorder.
    Young LD; Patel M; Keeler MH
    Curr Alcohol; 1981; 8():175-81. PubMed ID: 6806015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some current thoughts on lithium carbonate in manic-depressive illness based on a double-blind comparison with chlorpromazine.
    Spring GK
    Psychosomatics; 1971; 12(5):336-40. PubMed ID: 4950864
    [No Abstract]   [Full Text] [Related]  

  • 48. Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study.
    Pickar D; Vartanian F; Bunney WE; Maier HP; Gastpar MT; Prakash R; Sethi BB; Lideman R; Belyaev BS; Tsutsulkovskaja MV; Jungkunz G; Nedopil N; Verhoeven W; van Praag H
    Arch Gen Psychiatry; 1982 Mar; 39(3):313-9. PubMed ID: 6121545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables.
    Maj M; Del Vecchio M; Starace F; Pirozzi R; Kemali D
    Acta Psychiatr Scand; 1984 Jan; 69(1):37-44. PubMed ID: 6422702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The multiple valences of lithium therapy].
    Balan GM; Balan M; Balan OG; Sibi M
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(3):465-9. PubMed ID: 6443620
    [No Abstract]   [Full Text] [Related]  

  • 51. Lithium versus placebo in acute depression: a clinical trial.
    Khan MC; Wickham EA; Reed JV
    Int Clin Psychopharmacol; 1987 Jan; 2(1):47-54. PubMed ID: 3117877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The risks and benefits of clozapine versus chlorpromazine.
    Claghorn J; Honigfeld G; Abuzzahab FS; Wang R; Steinbook R; Tuason V; Klerman G
    J Clin Psychopharmacol; 1987 Dec; 7(6):377-84. PubMed ID: 3323261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lithium response in the treatment of manic symptomatology.
    Channabasavanna SM; Sampath G; Rao BS; Kumar YV; Krishna DK
    Indian J Med Res; 1980 Dec; 72():908-9. PubMed ID: 7228201
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacotherapy of impaired affect in recovering schizophrenic patients.
    Hogarty GE; McEvoy JP; Ulrich RF; DiBarry AL; Bartone P; Cooley S; Hammill K; Carter M; Munetz MR; Perel J
    Arch Gen Psychiatry; 1995 Jan; 52(1):29. PubMed ID: 7811160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbamazepine and lithium: different profiles in affective disorder?
    Lerer B; Moore N; Meyendorff E; Cho SR; Gershon S
    Psychopharmacol Bull; 1985; 21(1):18-22. PubMed ID: 3885293
    [No Abstract]   [Full Text] [Related]  

  • 56. New applications of lithium therapy.
    Murray JB
    J Psychol; 1990 Jan; 124(1):55-73. PubMed ID: 2108242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lithium response and psychoses: a double-blind, placebo-controlled study.
    Garver DL; Hirschowitz J; Fleishmann R; Djuric PE
    Psychiatry Res; 1984 May; 12(1):57-68. PubMed ID: 6087397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
    Bowers MB; Mazure CM; Nelson JC; Jatlow PI
    Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.
    Placidi GF; Lenzi A; Lazzerini F; Cassano GB; Akiskal HS
    J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1985; 85(1):8-13. PubMed ID: 3920702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.